Skip to content

Evaluation of safety and effectiveness of Eczacin cream in improving atopic dermatitis

Evaluation of safety and effectiveness of Eczacin cream made by Pharmed Salamat Sina company in improving mild and moderate atopic dermatitis in adults

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210130050179N2
Enrollment
19
Registered
2021-12-09
Start date
2021-12-06
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis. Atopic dermatitis

Interventions

Intervention group: Use Eczacin Repairing Cream product by Sina pharmed salamat twice a day for 4 weeks.

Sponsors

Sina pharmed salamat
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Chronic or recurrent eczema with a mild to moderate severity and personal or family history of Atopia or high IgE level Signing the consent form for participation in the study Minimum score of one for the SCORAD (Severity Scoring of Atopic Dermatitis index) scale of redness and itching

Exclusion criteria

Exclusion criteria: Not to use topical medications for Atopic Dermatitis (except for moisturizer) in the last 2 weeks or systemic medications in the last 4 weeks. Use of steroids or systemic immunosuppressive drugs with any indication. Pregnancy or lactating Severe atopic dermatitis (SCORAD above 12)

Design outcomes

Primary

MeasureTime frame
Local SCORAD (Severity Scoring of Atopic Dermatitis index) criteria. Timepoint: Before intervention and 2 and 4 weeks after treatment. Method of measurement: Research physician will perform clinical assessments according to the local SCORAD (Severity Scoring of Atopic Dermatitis index) grade.

Secondary

MeasureTime frame
Trans epidermal water loss. Timepoint: Before intervention and 2 and 4 weeks after treatment. Method of measurement: Tewameter.;Stratum corneum hydration. Timepoint: Before intervention and 2 and 4 weeks after treatment. Method of measurement: Corneometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTaraneh Yazdanparast

Tehran University of Medical Sciences

drtaraneh@yahoo.com+98 21 8896 0880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026